News
PredicineCARE, a urine-based test, is under FDA review as a companion diagnostic for bladder cancer, building on previous ...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today it has received CE IVDR approval for two label expansions for its VENTANA® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback